RecruitingNCT07286929

Evaluation of the Variation Over Time of Visuospatial Deficit in Patients With Parietal Lobe Glioma


Sponsor

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Enrollment

40 participants

Start Date

Dec 3, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of modern neurooncological surgery is to obtain maximum tumor resection while preserving neurological function. Parietal lobe gliomas often cause attention deficits (hemineglect) that are difficult to differentiate from other deficits. This study aims to evaluate the extent and variation over time of visuo-spatial deficits in patients undergoing surgical removal of parietal lobe gliomas. This will help characterize the cognitive profile of these patients to identify personalized treatment and rehabilitation paths.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patients \>18 years old
  • Patients must understand the Italian Language
  • Patients with suspected parietal lobe glioma

Exclusion Criteria6

  • Tumor site other than parietal lobe.
  • Patients who cannot undergo surgical resection (stereotactic/open biopsy).
  • Patients who received a previous chemotherapy and/or radiotherapy treatment.
  • Patients with a history of intracranial mass lesion or traumatic brain injury.
  • Patients with a history of other CNS diseases (e.g., stroke, metastasis).
  • Patients with diagnosis of neurodegenerative disease (i.e. Alzheimer's Disease, Frontotemporal Dementia, Parkinson's Disease, Lewy Body Dementia, Amyotrophic Lateral Sclerosis).

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Fondazione IRCCS Istituto Neurologico Carlo Besta

Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07286929


Related Trials